Bevacizumab 对视网膜色素上皮细胞纤维化相关因子表达的影响
发布时间:2019-05-14 04:53
【摘要】:目的观察Bevacizumab对人视网膜色素上皮细胞纤维化相关因子基因及蛋白表达的影响,探讨Bevacizumab在新生血管纤维化中的作用。方法用含终浓度0.25 g·L-1Bevacizumab的DMED/F12培养液培养ARPE-19细胞,按Bevacizumab处理的时间分为0 h、6 h、12 h、24 h和48 h共5组,0 h为对照组。不同时间点收集细胞及上清。用逆转录聚合酶链反应检测ARPE-19细胞中结缔组织生长因子(connective tissue growth factor,CTGF)、碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)、转化生长因子-β2(transforming growth factorβ2,TGF-β2)和基质金属蛋白酶-2(matrix metalloproteinase 2,MMP-2)的mRNA相对表达量。采用ELISA检测上清中CTGF、bFGF和TGF-β2的蛋白浓度,应用免疫蛋白印迹法(Western blotting)检测MMP-2蛋白的表达。结果 Bevacizumab作用后6 h、12 h、24 h和48 h,CTGF、bFGF、TGF-β2及MMP-2的mRNA相对表达量分别为CTGF:1.694±0.160、1.994±0.221、1.733±0.057、1.397±0.075,bFGF:1.720±0.068、2.144±0.080、1.893±0.068、1.372±0.076,TGF-β2:1.356±0.070、1.737±0.515、1.576±0.098、1.439±0.050,MMP-2:1.414±0.115、1.644±0.094、1.435±0.075、1.285±0.024,与对照组相比均升高,差异均有统计学意义(均为P0.05)。ELISA结果显示Bevacizumab作用后6 h、12 h、24 h和48 h,CTGF、bFGF、TGF-β2蛋白的表达量与对照组相比均升高,差异均有统计学意义(均为P0.05);对照组及各时间组蛋白浓度分别为CTGF:(31.949±0.388)ng·L-1、(48.697±0.863)ng·L-1、(56.847±0.499)ng·L-1、(51.753±1.395)ng·L-1、(43.085±1.240)ng·L-1,bFGF:(26.660±1.360)ng·L-1、(46.529±3.297)ng·L-1、(55.883±1.705)ng·L-1、(47.937±1.303)ng·L-1、(36.894±2.532)ng·L-1,TGF-β2:(26.982±2.404)ng·L-1、(35.452±1.360)ng·L-1、(46.787±0.896)ng·L-1、(43.683±1.630)ng·L-1、(38.008±1.110)ng·L-1。Western blotting结果显示,Bevacizumb处理后6 h、12 h、24 h、48 h MMP-2蛋白含量升高,组间比较差异有统计学意义(F=2620.429,P=0.000)。结论 Bevacizumab能够上调人RPE细胞中CTGF、bFGF、TGF-β2及MMP-2的表达,可能有促纤维化形成的作用。
[Abstract]:Objective to observe the effect of Bevacizumab on the expression of fibrosis related factor gene and protein in human retinal pigment epithelial cells (RPE) and to explore the role of Bevacizumab in neovascularization. Methods ARPE-19 cells were cultured in DMED/F12 medium containing 0.25 g 路L-1Bevacizumab. According to the treatment time of Bevacizumab, ARPE-19 cells were divided into 5 groups for 0 h, 6 h, 12 h, 24 h and 48 h, and 0 h as control group. At different time points, cells and smears were collected. Connective tissue growth factor (connective tissue growth factor,CTGF, basic fibroblast growth factor (basic fibroblast growth factor,bFGF and transforming growth factor-尾 2 (transforming growth factor 尾 2 in ARPE-19 cells were detected by reverse transcription polymerase chain reaction (RT-PCR). The mRNA expression of TGF- 尾 2) and matrix metalloprotease-2 (matrix metalloproteinase 2 (MMP 鈮,
本文编号:2476452
[Abstract]:Objective to observe the effect of Bevacizumab on the expression of fibrosis related factor gene and protein in human retinal pigment epithelial cells (RPE) and to explore the role of Bevacizumab in neovascularization. Methods ARPE-19 cells were cultured in DMED/F12 medium containing 0.25 g 路L-1Bevacizumab. According to the treatment time of Bevacizumab, ARPE-19 cells were divided into 5 groups for 0 h, 6 h, 12 h, 24 h and 48 h, and 0 h as control group. At different time points, cells and smears were collected. Connective tissue growth factor (connective tissue growth factor,CTGF, basic fibroblast growth factor (basic fibroblast growth factor,bFGF and transforming growth factor-尾 2 (transforming growth factor 尾 2 in ARPE-19 cells were detected by reverse transcription polymerase chain reaction (RT-PCR). The mRNA expression of TGF- 尾 2) and matrix metalloprotease-2 (matrix metalloproteinase 2 (MMP 鈮,
本文编号:2476452
本文链接:https://www.wllwen.com/yixuelunwen/yank/2476452.html
最近更新
教材专著